Activation of the Akt-mTOR pathway and receptor tyrosine kinase in patients with solitary fibrous tumors.
about
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor.Late recurrence of a malignant hypoglycemia-inducing pelvic solitary fibrous tumor secreting high-molecular-weight insulin-like growth factor-II: A case report with protein analysis.Doege-Potter syndrome: A review of the literature including a new case report.Elevated expression of HSP90 and the antitumor effect of an HSP90 inhibitor via inactivation of the Akt/mTOR pathway in undifferentiated pleomorphic sarcoma.Update on Select Benign Mesenchymal and Meningothelial Sinonasal Tract LesionsThe pericyte antigen RGS5 in perivascular soft tissue tumorsEukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis.Activation of the Akt-mTOR and MAPK pathways in dedifferentiated liposarcomas.Eukaryotic Translation Initiation Factor 3b is both a Promising Prognostic Biomarker and a Potential Therapeutic Target for Patients with Clear Cell Renal Cell Carcinoma.Immunophenotype Heterogeneity in Nasal Glomangiopericytoma.Pericyte Antigens in Perivascular Soft Tissue Tumors.[Metabolic disorders as paraneoplastic syndromes].Soft tissue sarcomas: From a morphological to a molecular biological approach.
P2860
Q33276227-F3E22D91-B896-4D17-A6EB-7614CACF1093Q33433437-1204FD8D-C6D8-4138-8C3A-F7588EB96E47Q33443391-432FEAB4-5B7C-4A1A-8CBC-C94570588F13Q35821721-D2487977-A0FE-4B11-B439-CC38FFB0606CQ36558594-00840272-1863-4347-BC9A-7A46C0F71403Q36885284-A596EAE4-E09F-402E-B9BA-29A2420C91F5Q38717560-5DBCDE29-4CA2-47EA-BFCB-432241D01E08Q38823442-D6026DB6-0E6B-4B4D-998D-528E5C9606A4Q41721643-0C486C73-5EEE-42C6-9E9D-765228934E1EQ42117495-F4CE340C-A87F-4837-A53A-18E9D64099FDQ42617970-B5731839-5324-4D55-976A-21EDCE67DAE4Q49581415-7A958AF4-4F9B-4C6F-9E50-695365521711Q51817033-9F46911F-B6AF-410C-9B6A-B05526F7DCD0
P2860
Activation of the Akt-mTOR pathway and receptor tyrosine kinase in patients with solitary fibrous tumors.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Activation of the Akt-mTOR pat ...... with solitary fibrous tumors.
@ast
Activation of the Akt-mTOR pat ...... with solitary fibrous tumors.
@en
type
label
Activation of the Akt-mTOR pat ...... with solitary fibrous tumors.
@ast
Activation of the Akt-mTOR pat ...... with solitary fibrous tumors.
@en
prefLabel
Activation of the Akt-mTOR pat ...... with solitary fibrous tumors.
@ast
Activation of the Akt-mTOR pat ...... with solitary fibrous tumors.
@en
P2093
P2860
P356
P1433
P1476
Activation of the Akt-mTOR pat ...... with solitary fibrous tumors.
@en
P2093
Fumiyoshi Fushimi
Hidetaka Yamamoto
Kenichi Kohashi
Makoto Endo
Nokitaka Setsu
Shoji Tokunaga
Yoshinao Oda
Yuichi Yamada
Yukihide Iwamoto
Yusuke Takahashi
P2860
P304
P356
10.1002/CNCR.28506
P407
P577
2013-12-18T00:00:00Z